Clene Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.89

-0.04 (-0.81%)

As of Apr 1, 10:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +285.7% upside

Low Target $15.04

Average Target $18.86

High Target $28.67

Current Price $4.89

Current
$4.89

Target
$18.86

$15.04 $18.86 avg $28.67

Scenario Analysis

Bear Case

$15.04

207.6%

Low target

Base Case

$18.86

+285.7%

Avg target

Bull Case

$28.67

+486.3%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$13.50

-63.8% from high

52-Week Low

$2.28

+114.5% from low

Target vs 52W High

$18.86

+39.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%